Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Credit agrmnt [a]
Appointed director
|
|
Kadmon Holdings, Inc. (KDMN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/05/2020 |
GN
| Kadmon Highlights Recent Progress and Reports Fourth Quarter and Full Year 2019 Financial Results |
| 04/03/2019 |
GN
| Research Report Identifies At Home Group, Commercial Metals, CarGurus, Kadmon, The Manitowoc, and Golden Entertainment with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement |
| 02/11/2019 |
GN
| Kadmon Announces Appointment of Steven Meehan as CFO |
| 01/28/2019 |
GN
| New Research: Key Drivers of Growth for Real Goods Solar, Standard Motor Products, Progress Software, Avon Products, Natus Medical, and Kadmon — Factors of Influence, Major Initiatives and Sustained Production |
| 01/23/2019 |
GN
| Kadmon Announces Appointment of Cynthia Schwalm to Board of Directors |
| 12/27/2018 |
GN
| Kadmon Chairman Bart M. Schwartz to Step Down from Board |
| 12/03/2018 |
GN
| Kadmon Announces Updated Findings from Ongoing Phase 2 Clinical Trial of KD025 in cGVHD at ASH Annual Meeting |
| 11/29/2018 |
GN
| Kadmon Presents Data on New ROCK Inhibitor Clinical Candidate at Anti-Fibrotic Drug Development Summit |
| 11/28/2018 |
GN
| Consolidated Research: 2018 Summary Expectations for Kadmon, Overstock, AECOM, Steelcase, CorMedix, and Corindus Vascular Robotics — Fundamental Analysis, Key Performance Indications |
| 11/06/2018 |
GN
| Kadmon Presents New Preclinical Data on its Immuno-Oncology Fusion Protein at SITC Annual Meeting |
| 10/17/2018 |
GN
| FDA Grants Breakthrough Therapy Designation to Kadmon's KD025 for Chronic Graft-Versus-Host Disease |
|
|